The EGFR mutational status of 132 retrospective clinical FFPE samples from patients with primary or metastatic NSCLC was tested with IdyllaTM System (IdyllaTM), and results were compared with the original assessments made by Therascreen® EGFR RGQ PCR Kit (version 2). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.